Immunohistochemistry (IHC) Cost Per Test, Service and Reagents

The Defense Health Agency has published a Notice of Intent to award a sole source Firm-Fixed-Price contract to Roche Diagnostics Corp for Immunohistochemistry (IHC) Cost Per Test, Service and Reagents for the Anatomic Pathology Laboratory at Naval Medical Center Portsmouth. The contract structure includes one base year with four option years, with performance beginning October 1, 2025 and running through September 30, 2026. The government has determined that Roche Diagnostics Corp is the only available source capable of providing the required IHC services and reagents. This special notice serves as formal notification of the government's intent to proceed with a non-competitive award. The opportunity falls under the Analytical Laboratory Instrument Manufacturing NAICS code and Medical and Surgical Instruments PSC category.

The primary purpose of this notice is to provide potential competitors an opportunity to challenge the sole source determination by demonstrating that competition would benefit the government without being cost or time prohibitive or hindering mission objectives. Interested parties must submit responses by September 18, 2025, providing clear and convincing evidence that competitive procurement would be advantageous. All questions and comments should be directed to Contract Specialist Kimberly Bunn via email with "Notice of Intent Submission 0012328326" in the subject line. The government emphasizes that this notice does not constitute a request for quotes or proposals, and respondents will bear all costs associated with preparing submissions. The final decision on whether to proceed with competitive procurement remains solely at the government's discretion, and responses will be evaluated primarily to determine if a competitive process should be initiated.